These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3806602)
1. Dopamine agonists related to 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzaz epi ne-7, 8-diol. 6-Position modifications. Ross ST; Franz RG; Gallagher G; Brenner M; Wilson JW; DeMarinis RM; Hieble JP; Sarau HM J Med Chem; 1987 Jan; 30(1):35-40. PubMed ID: 3806602 [TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro- 1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines. Ross ST; Franz RG; Wilson JW; Brenner M; DeMarinis RM; Hieble JP; Sarau HM J Med Chem; 1986 May; 29(5):733-40. PubMed ID: 2871192 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam. Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077 [TBL] [Abstract][Full Text] [Related]
4. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue. Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424 [TBL] [Abstract][Full Text] [Related]
5. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist. Blumberg AL; Wilson JW; Hieble JP J Cardiovasc Pharmacol; 1985; 7(4):723-32. PubMed ID: 2410714 [TBL] [Abstract][Full Text] [Related]
15. A dopamine- and octopamine-sensitive adenylate cyclase in the nervous system of Octopus vulgaris. Capasso A; Carginale V; Madonna L; Mancaniello D; Scudiero R; Paolo De Prisco P; De Petrocellis B; Parisi E Comp Biochem Physiol B; 1991; 100(4):805-8. PubMed ID: 1782763 [TBL] [Abstract][Full Text] [Related]
16. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822. Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors. Dahmer MK; Senogles SE J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958 [TBL] [Abstract][Full Text] [Related]